SBI Innovative Opportunities Fund - Direct (G) - NFO
Scheme Objective
The investment objective of the scheme is to provide investors with opportunities for long term capital appreciation by investing in equity and equity related instruments of companies that seeks to benefit from adoption of innovative strategies & theme. However, there is no assurance that the investment objective of the scheme will be achieved.
Fund House Details
SBI Mutual Fund
| Fund Name | Rating | 3 Year CAGR | 5 Year CAGR |
|---|---|---|---|
|
SBI PSU Fund - Direct Growth |
0★ | 34.52% | 24.74% |
|
SBI Infrastructure Fund - Direct Growth |
3★ | 25.30% | 26.20% |
|
SBI Healthcare Opportunities Fund - Direct Growth |
4★ | 23.93% | 29.88% |
|
SBI Contra Fund - Direct Growth |
5★ | 23.28% | 30.34% |
|
SBI Long Term Equity Fund - Direct Growth |
5★ | 23.05% | 24.75% |
Fund House Contact Details
FAQs
The investment objective of the scheme is to provide investors with opportunities for long term capital appreciation by investing in equity and equity related instruments of companies that seeks to benefit from adoption of innovative strategies & theme. However, there is no assurance that the investment objective of the scheme will be achieved.
Open date of SBI Innovative Opportunities Fund - Direct (G) 29 Jul 2024
Close date of SBI Innovative Opportunities Fund - Direct (G) 12 Aug 2024
The minimum investment amount of SBI Innovative Opportunities Fund - Direct (G) ₹5000
The Fund Manger of SBI Innovative Opportunities Fund - Direct (G) is Prasad Padala
Mutual fund Blogs
Market Outlook for 21st November 2024
Nifty Prediction for 21st November The Nifty index broke its seven-day losing streak, closing above...
Stock in Action Federal Bank 19 November 2024
Highlights 1. Federal shares saw a marginal rise, trading at ₹ 197.60 with an intraday high of ...
Onyx Biotec IPO Allotment Status
Summary Onyx Biotec IPO has closed with an extraordinary response from investors, achieving a remar...
